Integra LifeSciences Holdings Corporation will release its second quarter 2026 financial results on Wednesday, July 29, 2026, prior to the market open. The announcement will provide insights into the company's performance for the quarter, with stakeholders keenly awaiting the details. Following the release, Integra’s management team will host a conference call at 8:30 a.m. ET to discuss the results and outlook.

A live webcast of the conference call will be available on the Investors section of the Company’s website at investor.integralife.com. Participants planning to join the call can register online to receive dial-in details and an individual pin. While registration is not mandatory, joining 10 minutes before the event starts is recommended to ensure a smooth connection.

For those unable to attend the live session, a webcast replay will be available on the Investors section of the Company’s website following the call. This ensures that all stakeholders have access to the financial updates and management commentary.

Integra LifeSciences is a global medical technology leader focused on neurosurgery and tissue reconstruction. The company’s portfolio includes highly differentiated technologies trusted by healthcare professionals for life-saving care. For further information, stakeholders can visit the company’s official website or contact investor relations.

BMO Capital analyst Vik Chopra has initiated coverage on Integra Lifesciences (NASDAQ: IART) with a Market Perform rating and a price target of $19. This new assessment provides a fresh valuation perspective on the medical technology company's stock performance.

Rating and Target Details

The brokerage firm's decision to assign a Market Perform rating suggests a balanced view of the stock's potential relative to the broader market. The price target of $19 establishes a specific valuation benchmark for investors monitoring the company.